Detailed information for compound 314615

Basic information

Technical information
  • TDR Targets ID: 314615
  • Name: 1-benzyl-4-(3,4-dihydro-2H-chromen-3-ylmethyl )piperazine
  • MW: 322.444 | Formula: C21H26N2O
  • H donors: 0 H acceptors: 0 LogP: 3.53 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: c1ccc(cc1)CN1CCN(CC1)CC1COc2c(C1)cccc2
  • InChi: 1S/C21H26N2O/c1-2-6-18(7-3-1)15-22-10-12-23(13-11-22)16-19-14-20-8-4-5-9-21(20)24-17-19/h1-9,19H,10-17H2
  • InChiKey: QDCUYFUPXSPBMW-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-benzyl-4-(chroman-3-ylmethyl)piperazine
  • 1-benzyl-4-(3,4-dihydro-2H-1-benzopyran-3-ylmethyl)piperazine
  • 1-(3,4-dihydro-2H-chromen-3-ylmethyl)-4-(phenylmethyl)piperazine
  • 1-(chroman-3-ylmethyl)-4-(phenylmethyl)piperazine
  • 1-(3-chromanylmethyl)-4-(phenylmethyl)piperazine
  • 1-(benzyl)-4-(chroman-3-ylmethyl)piperazine

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled Starlite/ChEMBL References
Homo sapiens sigma non-opioid intracellular receptor 1 Starlite/ChEMBL References
Homo sapiens adrenoceptor alpha 2C Starlite/ChEMBL References
Homo sapiens adrenoceptor alpha 2A Starlite/ChEMBL References
Homo sapiens adrenoceptor alpha 2B Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Leishmania major C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Echinococcus multilocularis serotonin receptor Get druggable targets OG5_133249 All targets in OG5_133249
Echinococcus granulosus biogenic amine 5HT receptor Get druggable targets OG5_133249 All targets in OG5_133249
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131051 All targets in OG5_131051
Candida albicans sterol C8-C7 isomerase Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma brucei gambiense C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania braziliensis C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma cruzi C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania mexicana C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Trypanosoma brucei C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Echinococcus multilocularis serotonin receptor Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma japonicum expressed protein Get druggable targets OG5_133249 All targets in OG5_133249
Trypanosoma congolense C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131051 All targets in OG5_131051
Schistosoma mansoni biogenic amine (5HT) receptor Get druggable targets OG5_133249 All targets in OG5_133249
Leishmania infantum C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051
Candida albicans sterol C8-C7 isomerase Get druggable targets OG5_131051 All targets in OG5_131051
Brugia malayi ERG2 and Sigma1 receptor like protein Get druggable targets OG5_131051 All targets in OG5_131051
Schistosoma japonicum ko:K04153 5-hydroxytryptamine (serotonin) receptor 1A, putative Get druggable targets OG5_133249 All targets in OG5_133249
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_133249 All targets in OG5_133249
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_133249 All targets in OG5_133249
Schistosoma japonicum Octopamine receptor, putative Get druggable targets OG5_133249 All targets in OG5_133249
Trypanosoma congolense C-8 sterol isomerase, putative Get druggable targets OG5_131051 All targets in OG5_131051
Leishmania donovani C-8 sterol isomerase-like protein Get druggable targets OG5_131051 All targets in OG5_131051

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis glutaminase, putative 0.0276 0.5917 1
Loa Loa (eye worm) hypothetical protein 0.0445 1 1
Plasmodium falciparum thioredoxin reductase 0.0089 0.1406 1
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0203 0.4162 0.8837
Loa Loa (eye worm) hypothetical protein 0.0036 0.0124 0.0087
Echinococcus granulosus para nitrobenzyl esterase 0.0036 0.0124 0.0281
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0036 0.0124 0.0202
Brugia malayi Carboxylesterase family protein 0.0036 0.0124 0.0124
Loa Loa (eye worm) thioredoxin reductase 0.0089 0.1406 0.1374
Mycobacterium ulcerans carboxylesterase, LipT 0.0036 0.0124 0.0209
Loa Loa (eye worm) hypothetical protein 0.0036 0.0124 0.0087
Echinococcus granulosus neuroligin 0.0036 0.0124 0.0281
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0036 0.0124 0.0209
Giardia lamblia NADH oxidase lateral transfer candidate 0.0031 0 0.5
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0089 0.1406 0.2985
Brugia malayi Carboxylesterase family protein 0.0213 0.4398 0.4398
Echinococcus multilocularis BC026374 protein (S09 family) 0.0036 0.0124 0.0281
Echinococcus multilocularis family S9 non peptidase ue (S09 family) 0.0036 0.0124 0.0281
Onchocerca volvulus 0.0036 0.0124 0.5
Loa Loa (eye worm) hypothetical protein 0.0036 0.0124 0.0087
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0036 0.0124 0.0263
Loa Loa (eye worm) glutaminase 2 0.0276 0.5917 0.5901
Mycobacterium tuberculosis Probable dehydrogenase 0.0203 0.4162 0.8837
Toxoplasma gondii thioredoxin reductase 0.0089 0.1406 1
Echinococcus multilocularis para nitrobenzyl esterase 0.0036 0.0124 0.0281
Echinococcus granulosus family S9 non peptidase ue S09 family 0.0036 0.0124 0.0281
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0203 0.4162 0.8837
Treponema pallidum NADH oxidase 0.0031 0 0.5
Echinococcus granulosus biogenic amine 5HT receptor 0.0159 0.3086 0.7016
Schistosoma mansoni acetylcholinesterase 0.0036 0.0124 0.0202
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0031 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0213 0.4398 0.4377
Leishmania major C-8 sterol isomerase-like protein 0.0445 1 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.0031 0 0.5
Brugia malayi Carboxylesterase family protein 0.0036 0.0124 0.0124
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0213 0.4398 0.7178
Trypanosoma cruzi trypanothione reductase, putative 0.0089 0.1406 0.1406
Loa Loa (eye worm) hypothetical protein 0.0159 0.3086 0.306
Entamoeba histolytica Acid sphingomyelinase-like phosphodiesterase, putative 0.0085 0.1302 0.5
Echinococcus multilocularis serotonin receptor 0.0159 0.3086 0.7016
Trypanosoma brucei trypanothione reductase 0.0089 0.1406 0.1406
Schistosoma mansoni gliotactin 0.0036 0.0124 0.0202
Echinococcus granulosus BC026374 protein S09 family 0.0036 0.0124 0.0281
Echinococcus multilocularis serotonin receptor 0.0159 0.3086 0.7016
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.0226 0.471 1
Entamoeba histolytica Acid sphingomyelinase-like phosphodiesterase, putative 0.0085 0.1302 0.5
Trypanosoma cruzi C-8 sterol isomerase, putative 0.0445 1 1
Loa Loa (eye worm) carboxylesterase 0.0036 0.0124 0.0087
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0036 0.0124 0.0263
Loa Loa (eye worm) hypothetical protein 0.0036 0.0124 0.0087
Loa Loa (eye worm) glutaminase 0.0276 0.5917 0.5901
Plasmodium vivax glutathione reductase, putative 0.0089 0.1406 1
Plasmodium vivax thioredoxin reductase, putative 0.0089 0.1406 1
Leishmania major trypanothione reductase 0.0089 0.1406 0.1406
Echinococcus granulosus acetylcholinesterase 0.0213 0.4398 1
Echinococcus granulosus carboxylesterase 5A 0.0213 0.4398 1
Brugia malayi glutathione reductase 0.0089 0.1406 0.1406
Loa Loa (eye worm) hypothetical protein 0.0213 0.4398 0.4377
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0036 0.0124 0.0202
Schistosoma mansoni glutaminase 0.0276 0.5917 0.9656
Loa Loa (eye worm) acetylcholinesterase 1 0.0213 0.4398 0.4377
Loa Loa (eye worm) hypothetical protein 0.0227 0.4747 0.4727
Brugia malayi Carboxylesterase family protein 0.0213 0.4398 0.4398
Loa Loa (eye worm) hypothetical protein 0.0036 0.0124 0.0087
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0203 0.4162 0.8837
Schistosoma mansoni neuroligin 3 (S09 family) 0.0036 0.0124 0.0202
Loa Loa (eye worm) glutathione reductase 0.0089 0.1406 0.1374
Schistosoma mansoni BC026374 protein (S09 family) 0.0036 0.0124 0.0202
Onchocerca volvulus 0.0036 0.0124 0.5
Loa Loa (eye worm) carboxylesterase 0.0036 0.0124 0.0087
Mycobacterium tuberculosis Probable oxidoreductase 0.0226 0.471 1
Brugia malayi Cytochrome P450 family protein 0.0032 0.0037 0.0037
Mycobacterium tuberculosis Carboxylesterase LipT 0.0036 0.0124 0.0263
Brugia malayi Thioredoxin reductase 0.0089 0.1406 0.1406
Echinococcus multilocularis neuroligin 0.0036 0.0124 0.0281
Brugia malayi Carboxylesterase family protein 0.0036 0.0124 0.0124
Brugia malayi hypothetical protein 0.0036 0.0124 0.0124
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0203 0.4162 0.8837
Plasmodium falciparum glutathione reductase 0.0089 0.1406 1
Schistosoma mansoni biogenic amine (5HT) receptor 0.0159 0.3086 0.5036
Loa Loa (eye worm) carboxylesterase 0.0213 0.4398 0.4377
Brugia malayi glutaminase DH11.1 0.0276 0.5917 0.5917
Mycobacterium tuberculosis Probable reductase 0.0203 0.4162 0.8837
Echinococcus granulosus thioredoxin glutathione reductase 0.009 0.1418 0.3225
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.0226 0.471 1
Echinococcus granulosus acetylcholinesterase 0.0213 0.4398 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0036 0.0124 0.0202
Echinococcus multilocularis acetylcholinesterase 0.0213 0.4398 1
Loa Loa (eye worm) hypothetical protein 0.0159 0.3086 0.306
Loa Loa (eye worm) hypothetical protein 0.0036 0.0124 0.0087
Trichomonas vaginalis spcc417.12 protein, putative 0.0036 0.0124 0.0209
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.0031 0 0.5
Onchocerca volvulus 0.0036 0.0124 0.5
Loa Loa (eye worm) hypothetical protein 0.0085 0.1302 0.1269
Onchocerca volvulus 0.0036 0.0124 0.5
Loa Loa (eye worm) hypothetical protein 0.0036 0.0124 0.0087
Onchocerca volvulus 0.0036 0.0124 0.5
Trypanosoma brucei C-8 sterol isomerase, putative 0.0445 1 1
Mycobacterium ulcerans glutaminase 0.0276 0.5917 1
Echinococcus multilocularis acetylcholinesterase 0.0213 0.4398 1
Brugia malayi Carboxylesterase family protein 0.0036 0.0124 0.0124
Echinococcus multilocularis thioredoxin glutathione reductase 0.009 0.1418 0.3225
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.0226 0.471 1
Echinococcus multilocularis carboxylesterase 5A 0.0213 0.4398 1

Activities

Activity type Activity value Assay description Source Reference
Inhibition (binding) = 29 % Percentage inhibition of dopamine D2 receptor at 10 uM concentration using 0.2 nM [3H]-spiperone ChEMBL. 15634021
Inhibition (binding) = 29 % Percentage inhibition of dopamine D2 receptor at 10 uM concentration using 0.2 nM [3H]-spiperone ChEMBL. 15634021
Ki (functional) Antagonist activity at human recombinant adrenergic alpha2B receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR ChEMBL. 18799310
Ki (functional) Antagonist activity at human recombinant adrenergic Alpha-2C receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR ChEMBL. 18799310
Ki (functional) Antagonist activity at human recombinant adrenergic alpha2A receptor expressed in CHO cells assessed as inhibition of NE-induced calcium mobilization by FLIPR ChEMBL. 18799310
Ki (binding) 0 nM Inhibitory constant against dopamine D2 receptor using 0.2 nM [3H]-spiperone; Not determined ChEMBL. 15634021
Ki (binding) = 0.3 nM Inhibitory constant against sigma receptor type 1 using 3 nM [3H]-pentazocine ChEMBL. 15634021
Ki (binding) = 0.3 nM Inhibitory constant against sigma receptor type 1 using 3 nM [3H]-pentazocine ChEMBL. 15634021
Ki (binding) = 1.48 nM Inhibitory constant against sigma receptor type 2 using 3 nM [3H]-ditolylguanidine ChEMBL. 15634021
Ki (binding) = 1.48 nM Inhibitory constant against sigma receptor type 2 using 3 nM [3H]-ditolylguanidine ChEMBL. 15634021
Ki (binding) > 500 nM Binding affinity at human recombinant adrenergic Alpha-2C receptor expressed in CHO cells by radioligand binding assay ChEMBL. 18799310
Ki (binding) > 500 nM Binding affinity at human recombinant adrenergic alpha2B receptor expressed in CHO cells by radioligand binding assay ChEMBL. 18799310
Ki (binding) > 500 nM Binding affinity at human recombinant adrenergic alpha2A receptor expressed in CHO cells by radioligand binding assay ChEMBL. 18799310
Ki (binding) > 1000 nM Inhibitory constant was determined against 5-hydroxytryptamine 1A receptor using 1.2 nM [3H]-8-OH-DPAT ChEMBL. 15634021
Ki (binding) > 1000 nM Inhibitory constant was determined against 5-hydroxytryptamine 1A receptor using 1.2 nM [3H]-8-OH-DPAT ChEMBL. 15634021
Ratio (binding) = 5 Ratio of Ki against Sigma receptor type 1 and 2 ChEMBL. 15634021
Ratio (binding) = 5 Ratio of Ki against Sigma receptor type 1 and 2 ChEMBL. 15634021

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

2 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.